Expert consensus on the use of omalizumab in chronic urticaria in China()

Chronic urticaria (CU) is a debilitating skin disease that lasts for more than 6 weeks with wheals and/or angioedema, including chronic spontaneous urticaria (CSU) and chronic inducible urticaria (CIndU). In China, the prevalence of this disease is high, more than 1%, and on the rise. CU has a major...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Zuotao, Cai, Tao, Chen, Hong, Chen, Liuqing, Chen, Yudi, Gao, Xiang, Gao, Xinghua, Geng, Songmei, Guo, Yinshi, Hao, Fei, Hao, Guodong, Hu, Yan, Jin, Hongzhong, Jin, Zhehu, Li, Chengxin, Li, Haili, Li, Jie, Li, Yanming, Liang, Yunsheng, Liu, Guanghui, Liu, Qiang, Long, Hai, Ma, Lin, Shang, Yuanyuan, Song, Yuxin, Song, Zhiqiang, Su, Xiangyang, Sui, Haijing, Sun, Qing, Sun, Yuemei, Tang, Jianping, Tong, Xunliang, Wang, Huiying, Wang, Gang, Wang, Lianglu, Wang, Siqin, Xiang, Li, Xiao, Ting, Xie, Zhiqiang, Ye, Leping, Yu, Yongmei, Zhang, Chunlei, Zhang, Litao, Zhang, Shuchen, Zheng, Rui, Zhi, Lili, Zhou, Wei, Zou, Ying, Maurer, Marcus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8654989/
https://www.ncbi.nlm.nih.gov/pubmed/34934470
http://dx.doi.org/10.1016/j.waojou.2021.100610

Ejemplares similares

Ejemplares similares